COVID-19 vaccines: Gates Foundation offers USD 70 million additional funding Ruchika Sharma15 Nov 2020 11:30 AM ISTNew Delhi: The Gates Foundation added another USD 70 million of funding on Thursday to global efforts to develop and distribute vaccines and...
Enough data for first interim analysis of late-stage trial of COVID vaccine: Moderna Ruchika Sharma15 Nov 2020 9:30 AM ISTNew Delhi: Moderna Inc said on Wednesday it has enough data for a first interim analysis of the late-stage trial of its experimental COVID-19...
Dalmia gets Ayush Ministry nod to manufacture ASTHA-15 for Covid treatment Ruchika Sharma14 Nov 2020 12:00 PM ISTNoida: In possibly, the proudest reason for India to cheer about during these pandemic times, Dalmia Healthcare Limited very soon will be announcing...
Punjab Govt appoints 482 Medical Officers to meet doctor shortage Medical Dialogues Bureau14 Nov 2020 10:00 AM ISTThe move, which will give a boost to Punjab's fight against Covid, is also part of the state government's strategic focus on providing employment to...
Pfizer, Israel strike deal for 8 million doses of potential COVID19 vaccine Ruchika Sharma13 Nov 2020 6:35 PM ISTIn televised remarks, Netanyahu said the agreement marked "a great day for Israel" and added: "The goal is for the vaccine supply to start in January...
Covid Bed Crunch at IGMC Hospital: HC directs Himachal Govt to file reply Medical Dialogues Bureau13 Nov 2020 10:30 AM ISTExtremely perturbed over the reports relating to the plight of the Covid patients, Himachal Pradesh High Court took suo moto cognizance of the...
COVID vaccine: Russia claims Sputnik V shows 92 percent efficacy MD Bureau13 Nov 2020 10:00 AM ISTNew Delhi: Russia's National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund on Wednesday announced that the...
Zydus Cadila Covid therapy PegiHep completes Phase II trial Ruchika Sharma13 Nov 2020 10:00 AM ISTAhmedabad: Zydus Cadila, has recently announced that the company has successfully completed a Phase 2 clinical trial in COVID-19 patients with...
Fluvoxamine may prevent respiratory deterioration in COVID-19, reports JAMA Dr. Kamal Kant Kohli13 Nov 2020 8:31 AM ISTFirst publication of a placebo-controlled trial demonstrates that early treatment with antidepressant Fluvoxamine can prevent respiratory...
Serum Institute, ICMR complete enrolment for Phase III trials of COVISHIELD in India MD Bureau12 Nov 2020 11:16 AM ISTNew Delhi: The Serum Institute of India (SII) and the Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment for...
Intas Pharma launches immuno booster add on drug to standard Covid treatment Ruchika Sharma12 Nov 2020 11:15 AM ISTThymoquinone has been developed as a stable, standardized and ready-to-use tablet by Intas for the first time in the world.
PPI use worsens outcomes in COVID 19 patients, finds study Medha Baranwal12 Nov 2020 10:23 AM ISTDelhi: A recent study has shed more light on the association between the use of proton pump inhibitors (PPIs) and adverse clinical outcomes in...
